Quasar Medical, a global leader in the manufacturing of interventional and minimally invasive medical devices, has announced the opening of its newest manufacturing facility in Chonburi, Thailand. This achievement represents a key milestone in the company's ongoing global growth and underscores its dedication to providing high-quality, scalable solutions to customers worldwide.
The new facility builds on Quasar's initial investment in Thailand, announced at the 2025 groundbreaking. It is now the company's third site in the country. Located in Chonburi, this facility strengthens Quasar's regional manufacturing presence in Asia and improves its capacity to support both global and local "in-region, for-region" production strategies.
Designed to support high-volume manufacturing and complex device assembly, the new facility offers advanced capabilities in catheter systems, micro-assembly, and finished device production. It is poised to be a key provider of scalable, cost-effective solutions, enhance supply chain resilience, and accelerate time-to-market for customers.
By the end of 2026, the Thailand operation is projected to have approximately 1,200 staff members across manufacturing, engineering, quality, and operations.
In addition to Quasar's existing network across Asia, North America, and Europe, the new site enhances the company's vertically integrated CDMO model, covering everything from design and development to commercialisation.
